Randy Osborne

1 week ago | bioworld.com | Randy Osborne

Associate degree: PTC’s hints of phase II HD efficacy studiedPTC Therapeutics Inc. CEO Matthew Klein said the firm “achieved all we set out to [achieve] in phase II” with PTC-518 in Huntington’s disease (HD), but it wasn’t enough to excite Wall Street, as some questioned whether the level of associations between trial findings and efficacy would appease the U.S. FDA. Shares (NASDAQ:PTCT) ended May 5 at $40.65, down $9.30, or 18.6%. BioWorld Clinical Neurology/psychiatric Small molecule

1 week ago | bioworld.com | Randy Osborne

Oh them REMS: Cytokinetics heart-hit with FDA delayWall Street immediately set to weighing the long-term import of Cytokinetics Inc.’s regulatory delay with aficamten, but the short-term impact was evident, as shares (NASDAQ:CYTK) dipped to close May 2 at $37.35, a loss of $5.57 or 13%. BioWorld Regulatory Cardiovascular

2 weeks ago | bioworld.com | Randy Osborne

Home » AUA hoorays in bladder cancer for J&J, Urogen, moreAUA hoorays in bladder cancer for J&J, Urogen, moreClinical results offered at the recent meeting of the American Urological Association in Las Vegas signal that better treatments may lie ahead for non-muscle invasive bladder cancer. BioWorld Clinical Conferences Cancer Small molecule U.S.

2 weeks ago | bioworld.com | Randy Osborne

Home » Street’s syringe whinges, sales dip dog Regeneron’s Eylea in AMD BioWorld briefs for April 28, 2025. BioWorld MedTech briefs for April 29, 2025. The biggest M&A activity of the year arrived in the form of Merck KGaA’s earlier-disclosed agreement to buy Springworks Therapeutics Inc. for $47 per share in... The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...

2 weeks ago | medium.com | Randy Osborne

I was squinting at bottles of dish soap on a high shelf when the sudden blow knocked me sideways, an impact that landed slightly under my left shoulder. At the same instant in my lower peripheral vision a silvery-white streak flashed, which didn’t fully register until later. I staggered — one foot tangled with the other at the ankles, not a favorable pose for uprightness — but I kept my balance without sprawling to the floor.